logo
  

Central European Media Enterprises President & CEO Adrian Sarbu Resigns

Central European Media Enterprises Ltd. (CETV) announced that effective today Adrian Sarbu is resigning as President and Chief Executive Officer of the company.

The company said Sarbu has played a prominent role in the company for nearly two decades. Initially, he was the company's partner when the company launched Pro TV in Romania in 1995. Subsequently, he served as Chief Operating Officer of the Company from 2007 to 2009. Since 2009 he has been President and Chief Executive Officer.

The company said that, in order to ensure an orderly transition, Sarbu will continue to be employed by the company until January 1, 2014. The Board has designated Duco Sickinghe, a member of the Board, to lead a committee of directors to ensure a smooth business transition while the committee conducts a search for a permanent Chief Executive Officer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT